General Information of the Compound
Compound ID |
CP0092370
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
1-[2-[5-[(3-methyloxetan-3-yl)methoxy]benzimidazol-1-yl]quinolin-8-yl]piperidin-4-amine
Show/Hide
|
||||||||||||||||||
Synonyms |
1-(2-(5-((3-Methyloxetan-3-yl)methoxy)-1H-benzo-[d]imidazol-1-yl)quinolin-8-yl)piperidin-4-amine
1-[2-[5-[(3-Methyl-3-oxetanyl)methoxy]-1-benzimidazolyl]-8-quinolyl]-4-piperidinamine
1-[2-[5-[(3-methyloxetan-3-yl)methoxy]benzimidazol-1-yl]quinolin-8-yl]piperidin-4-amine
670220-88-9
ARO-002
CP-868,596
CP-868596
CP-868596 (Crenolanib)
CP868569
Crenolanib
Crenolanib (CP-868596)
J-502712
LQF7I567TQ
UNII-LQF7I567TQ
[1-[2-[5-(3-Methyloxetan-3-ylmethoxy)benzimidazol-1-yl]quinolin-8-yl]piperidin-4-yl]amine
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C26H29N5O2
|
||||||||||||||||||
Molecular Weight |
443.551
|
||||||||||||||||||
Canonical SMILES |
CC1(COc2ccc3n(cnc3c2)-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C26H29N5O2/c1-26(14-32-15-26)16-33-20-6-7-22-21(13-20)28-17-31(22)24-8-5-18-3-2-4-23(25(18)29-24)30-11-9-19(27)10-12-30/h2-8,13,17,19H,9-12,14-16,27H2,1H3
Show/Hide
|
||||||||||||||||||
InChIKey |
DYNHJHQFHQTFTP-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
670220-88-9
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Clinical Information about the Compound
Drug 1 ( CP-868596 )
Drug Name | CP-868596 | ||
---|---|---|---|
Company | Pfizer | ||
Indication | |||
Target(s) |
Platelet-derived growth factor receptor alpha (PDGFRA)
Modulator
|